Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Not Recommended, But Done: Breastfeeding with HIV in Germany.
Haberl L, Audebert F, Feiterna-Sperling C, Gillor D, Jakubowski P, Jonsson-Oldenbüttel C, Khaykin P, Kiener R, Reitter A, Rieke A, Rodríguez E, Rößler S, Rump JA, Schüttfort G, Stephan C, Ulmer A, von Braun A, von Weizsäcker K, Haberl A. Haberl L, et al. Among authors: schuttfort g. AIDS Patient Care STDS. 2021 Feb;35(2):33-38. doi: 10.1089/apc.2020.0223. AIDS Patient Care STDS. 2021. PMID: 33571048
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.
Donath M, Wolf T, Stürmer M, Herrmann E, Bickel M, Khaykin P, Göpel S, Gute P, Haberl A, de Leuw P, Schüttfort G, Berger A, Stephan C; for Frankfurt HIV Cohort Study. Donath M, et al. Among authors: schuttfort g. Med Microbiol Immunol. 2016 Dec;205(6):575-583. doi: 10.1007/s00430-016-0469-7. Epub 2016 Jul 28. Med Microbiol Immunol. 2016. PMID: 27469377
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years.
Krznaric I, Bickel M, Carganico A, De Leuw P, Haberl A, Knecht G, Koegl C, Lauscher P, Schüttfort G, Stephan C, Wolf E, Wolf T. Krznaric I, et al. Among authors: schuttfort g. HIV Med. 2018 Oct;19(9):662-667. doi: 10.1111/hiv.12636. Epub 2018 Jul 3. HIV Med. 2018. PMID: 29971922 Free article.
Influence of tenofovir exposure in utero on primary dentition.
Schüttfort G, Höfler S, Kann G, Königs C, de Leuw P, Herrmann E, Stephan C, Haberl A. Schüttfort G, et al. Eur J Pediatr. 2020 Nov;179(11):1761-1768. doi: 10.1007/s00431-020-03660-1. Epub 2020 May 19. Eur J Pediatr. 2020. PMID: 32424746
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control study.
Wetzstein N, Geil A, Kann G, Lehn A, Schüttfort G, Kessel J, Bingold TM, Küpper-Tetzel CP, Haberl A, Graf C, Vehreschild MJGT, Stephan C, Hogardt M, Wichelhaus TA, Wolf T. Wetzstein N, et al. Among authors: schuttfort g. PLoS One. 2021 Jul 13;16(7):e0254607. doi: 10.1371/journal.pone.0254607. eCollection 2021. PLoS One. 2021. PMID: 34255788 Free PMC article.
High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysis.
Wetzstein N, Kessel J, Bingold TM, Carney J, Graf C, Koch BF, Meier F, Baumgarten J, Küpper-Tetzel CP, Khodamoradi Y, Wolf T, Schüttfort G, Vehreschild MJGT, Wichelhaus TA, Stephan C. Wetzstein N, et al. Among authors: schuttfort g. J Infect. 2022 Jan;84(1):8-16. doi: 10.1016/j.jinf.2021.10.027. Epub 2021 Nov 14. J Infect. 2022. PMID: 34788633
28 results